Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aptevo Therapeutics Inc. - Common Stock (NQ:APVO)

1.565 +0.125 (+8.68%)
Streaming Delayed Price Updated: 1:28 PM EDT, Sep 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aptevo Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Let's uncover which stocks are experiencing notable gaps during today's session.
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session. 
Via Chartmill
Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML
Via ACCESS Newswire
Foremost Clean Energy and Aptevo Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESS Newswire
Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline to Five Molecules
Via ACCESS Newswire
Aptevo Highlights APVO442, a CD3-Directed Preclinical Candidate for Prostate Cancer
Via ACCESS Newswire
Aptevo Reports 85% Remission in Q2
Via The Motley Fool
Aptevo Therapeutics Reports 2Q25 Financial Results And Provides A Business Update
Via ACCESS Newswire
Aptevo Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESS Newswire
Benzinga Bulls And Bears: Circle, Sunrun, JetBlue — And Mideast Has Markets Nervous
Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
These stocks are moving in today's session
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
Aptevo Therapeutics Announces Closing of $8 Million Offering Priced At-the-Market Under Nasdaq Rules
Via ACCESS Newswire
Gapping stocks in Friday's session
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. 
Via Chartmill
Aptevo Expands Differentiated CD3 Portfolio with APVO455, Advancing a Suite of Targeted T-cell Engagers
Via ACCESS Newswire
Stay updated with the stocks that are on the move in today's pre-market session.
Discover the top movers in Friday's pre-market session and stay informed about market dynamics. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
 
Via Benzinga
Why Cheetah Mobile Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Top movers in Thursday's after hours session
Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
Which stocks are experiencing notable movement on Wednesday?
Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
Crude Oil Moves Higher; US Weekly Jobless Claims Decline
 
Via Benzinga
Discover the most active stocks in Wednesday's session.
Curious about the most active stocks on Wednesday? Find out which stocks are dominating the market action! 
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Dow Surges 150 Points; Korn Ferry Earnings Top Views
 
Via Benzinga
Topics Stocks
Here are the top movers in Wednesday's session.
Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
Aptevo Therapeutics Touts Data From Investigational Drug Trial For Aggressive Blood Cancer
Aptevo stock spikes as new AML trial data show 85% remission rate with mipletamig triplet therapy, supported by strong safety and no CRS observed. 
Via Benzinga
Aptevo Therapeutics Announces $8 Million Offering Priced At-the-Market Under Nasdaq Rules
Via ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Mipletamig Demonstrates Compelling Clinical Activity in Frontline AML
Via ACCESS Newswire
Aptevo Participating in the BIO International Convention
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.